S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Karen Kelly, MD
University of Colorado, Denver
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
163 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Alaska Regional Hospital
Anchorage, Alaska, United States
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Alta Bates Comprehensive Cancer Center
Berkeley, California, United States
- Peninsula Medical Center
Burlingame, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Marin Cancer Institute at Marin General Hospital
Greenbrae, California, United States
- Sutter Health Western Division Cancer Research Group
Greenbrae, California, United States
- Saint Rose Hospital
Hayward, California, United States
- Valley Memorial Hospital
Livermore, California, United States
- Usc/norris Comprehensive Cancer Center and Hospital
Los Angeles, California, United States
- Ccop - Bay Area Tumor Institute
Oakland, California, United States
- Highland General Hospital
Oakland, California, United States
- Summit Medical Center
Oakland, California, United States
- Comprehensive Cancer Center at Desert Regional Medical Center
Palm Springs, California, United States
- Sutter Roseville Medical Center
Roseville, California, United States
- Mercy General Hospital
Sacramento, California, United States
- Sutter Cancer Center
Sacramento, California, United States
- University of California Davis Cancer Center
Sacramento, California, United States
- California Pacific Medical Center - California Campus
San Francisco, California, United States
- J.C. Robinson, M.D. Regional Cancer Center
San Pablo, California, United States
- Ccop - Santa Rosa Memorial Hospital
Sana Rosa, California, United States
- St. Anthony Central Hospital
Denver, Colorado, United States
- University of Colorado Cancer Center at University of Colorado Health Sciences Center
Denver, Colorado, United States
- Veterans Affairs Medical Center - Denver
Denver, Colorado, United States
- Poudre Valley Hospital
Fort Collins, Colorado, United States
- Montrose Memorial Hospital Cancer Center
Montrose, Colorado, United States
- St. Anthony North Hospital
Westminster, Colorado, United States
- Exempla Lutheran Medical Center
Wheat Ridge, Colorado, United States
- Ccop - Atlanta Regional
Atlanta, Georgia, United States
- Northside Hospital Cancer Center
Atlanta, Georgia, United States
- Piedmont Hospital
Atlanta, Georgia, United States
- Saint Joseph'S Hospital of Atlanta
Atlanta, Georgia, United States
- Augusta Oncology Associates
Augusta, Georgia, United States
- Wellstar Cobb Hospital
Austell, Georgia, United States
- Charles B. Eberhart Cancer Center at Dekalb Medical Center
Decatur, Georgia, United States
- Northeast Georgia Medical Center
Gainesville, Georgia, United States
- Gwinnett Medical Center
Lawrenceville, Georgia, United States
- Kennestone Cancer Center at Wellstar Kennestone Hospital
Marietta, Georgia, United States
- Southern Regional Medical Center
Riverdale, Georgia, United States
- Curtis & Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center
Savannah, Georgia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2004
- Primary completion
- 31 Aug 2007
- Completion
- 31 Jul 2011
- Last update posted
- 1 Nov 2012
- Registered enrollment
- 242
- Registry id
- NCT00085501
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.